DOXY

This brand name is authorized in Nigeria. It is also authorized in France, Hong Kong SAR China, Israel, New Zealand, United States.

Active ingredients

The drug DOXY contains one active pharmaceutical ingredient (API):

1	Doxycycline UNII 19XTS3T51U - DOXYCYCLINE HYCLATE
	Doxycycline is primarily bacteriostatic and is believed to exert its antimicrobial effect by the inhibition of protein synthesis.
	Read more about Doxycycline

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7010	Tablet	Doxy 200 Tablets TAB 200 mg 1 X 8	46 RNW-PP-262567 Doxy 200 Tablets DOXYCYCLINE USP 200MG Doxycycline monohydrate 210.5 mg, Maize Starch 153.45 mg, Microcrystalline cellulose 123.79mg, Sodium Lauryl Sulfate 2.32mg, Sodium Methylparabon 0.55mg, Sodium Propyl para on 0.11mg, Anhydrous Colloidal Silicone 2.32?mg, Magnesium Stearate 5.28 mg, Talc 21.88mg B4-7010 Drugs Imported Products 1x8 Prescription Only Medicine (POM) 5/2/2022 EXPHARLAB LIMITED, 387, AGEGE MOTOR ROAD MUSHIN LAGOS 9030750939 expharlab@exphar.be GRACURE PHARMACEUTICAL LTD., E-1105 RIICO Industrial Area, Phase III BHIWADI, PIN-301019 Dist, Alwar, Rajasthan, India , India	06/07/2023

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DOXY Powder for solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01AA02	Doxycycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	61722191, 67061569
HK	Department of Health Drug Office	38107, 42036
IL	מִשְׂרַד הַבְּרִיאוּת	3532
NG	Registered Drug Product Database	B4-7010
NZ	Medicines and Medical Devices Safety Authority	2731, 2733
US	FDA, National Drug Code	51662-1402, 52584-028, 63323-130